References
- Dickson, M., & Gagnon, J. P. (2004). Key factors in the rising cost of new drug discovery and development. Nature Reviews Drug Discovery, 3, 417–429. doi:10.1038/nrd1382
- Gad, H., Koolmeister, T., Jemth, A. S., Eshtad, S., Jacques, S. A., Ström, C. E., … Helleday, T. (2014). MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool. Nature, 508, 215–221. doi:10.1038/nature13181
- Gupta, S. C., Sung, B., Prasad, S., Webb, L. J., & Aggarwal, B. B. (2013). Cancer drug discovery by repurposing: Teaching new tricks to old dogs. Trends in Pharmacological Sciences, 34, 508–517. doi:10.1016/j.tips.2013.06.005
- Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A., & Simmerling, C. (2006). Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins: Structure, Function, and Bioinformatics, 65, 712–725. doi:10.1002/prot.21123
- Iida, T., Furuta, A., Kawashima, M., Nishida, J., Nakabeppu, Y., & Iwaki, T. (2001). Accumulation of 8-oxo-2′-deoxyguanosine and increased expression of hMTH1 protein in brain tumors. Neuro-Oncology, 3, 73–81.
- Kennedy, C. H., Cueto, R., Belinsky, S. A., Lechner, J. F., & Pryor, W. A. (1998). Overexpression of hMTH1 mRNA: A molecular marker of oxidative stress in lung cancer cells. FEBS Letters, 429, 17–20.10.1016/S0014-5793(98)00505-5
- Kollman, P. A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., … Cheatham, T. E., 3rd. (2000). Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Accounts of Chemical Research, 33, 889–897. doi:10.1021/ar000033j
- Nakabeppu, Y. (2014). Cellular levels of 8-oxoguanine in either DNA or the nucleotide pool play pivotal roles in carcinogenesis and survival of cancer cells. International Journal of Molecular Sciences, 15, 12543–12557. doi:10.3390/ijms150712543
- Nakabeppu, Y., Ohta, E., & Abolhassani, N. (2016). MTH1 as a nucleotide pool sanitizing enzyme: Friend or foe? Free Radical Biology and Medicine, 107, 151–158. doi:10.1016/j.freeradbiomed.2016.11.002
- Pronk, S., Páll, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R., … Lindahl, E. (2013). GROMACS 4.5: A high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics, 29, 845–854. doi: 10.1093/bioinformatics/btt055
- Tsuzuki, T., Nakatsu, Y., & Nakabeppu, Y. (2007). Significance of error-avoiding mechanisms for oxidative DNA damage in carcinogenesis. Cancer Science, 98, 465–470. doi:10.1111/j.1349-7006.2007.00409.x
- Tu, Y., Wang, Z., Wang, X., Yang, H., Zhang, P., Johnson, M., … Cui, D. (2016). Birth of MTH1 as a therapeutic target for glioblastoma: MTH1 is indispensable for gliomatumorigenesis. American Journal of Translational Research, 8, 2803–2811.
- Wang, M., Zhou, S., Chen, Q., Wang, L., Liang, Z., & Wang, J. (2017). Understanding the molecular mechanism for the differential inhibitory activities of compounds against MTH1. Scientific Reports, 7, 40557. doi:10.1038/srep40557
- Wang, Z., Sun, H., Yao, X., Li, D., Xu, L., Li, Y., … Hou, T. (2016). Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: The prediction accuracy of sampling power and scoring power. Physical Chemistry Chemical Physics, 18, 12964–12975. doi:10.1039/c6cp01555 g
- Yoshimura, D., Sakumi, K., Ohno, M., Sakai, Y., Furuichi, M., Iwai, S., & Nakabeppu, Y. (2003). An oxidized purine nucleoside triphosphatase, MTH1, suppresses cell death caused by oxidative stress. Journal of Biological Chemistry, 278, 37965–37973. doi:10.1074/jbc.M306201200